The FDA issued a third complete response letter for ONS-5010/Lytenava, requesting confirmatory efficacy evidence for wet AMD treatment. Lytenava is an ophthalmic bevacizumab formulation, potentially ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

TLX591-CDx (Illuccix® in approved jurisdictions, 68 Ga-PSMA-11 ): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Botox can cause temporary redness, swelling, tenderness, or bruising at the injection site. You may get flu-like symptoms like fever, body aches, or nausea after Botox. Botox may cause headaches, ...